Adocia, Lilly (LLY) Report Positive Topline Results from Phase 1b Study of BioChaperone Lispro in Patients With Type 1 Diabetes
Tweet Send to a Friend
Adocia (Paris: ADOC) and Eli Lilly and Company (NYSE: LLY) announced today positive topline results from a Phase 1b clinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
